Latest Health News
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune…
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
June 15, 2026 16:05 ET | Source: Adaptive Biotechnologies Proceeds expected to…
Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development
The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process…
2026 EHA | Over 40 Orelabrutinib Studies Presented, Including First Clinical Data from Europe and US TN CLL/SLL Patients
BEIJING, June 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE:…
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
Poster presentations from ongoing clinical trials of two core assets, olverembatinib and…
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Achieved 100% ORR and 83.3% CR rate at dose level 2 following…
KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe…
Phase 3 Data Show TransCon PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism
June 13, 2026 16:00 ET | Source: Ascendis Pharma Multi-organ system and…
